Literature DB >> 11107192

Cortical malformations and epilepsy.

P A Schwartzkroin1, C A Walsh.   

Abstract

Brain malformations, resulting from aberrant patterns of brain development, are highly correlated with childhood seizure syndromes, as well as with cognitive disabilities and other neurological disorders. The structural malformations, often referred to as cortical dysplasia, are extremely varied, reflecting diverse underlying processes and critical timing of the developmental aberration. Recent studies have revealed a genetic basis for many forms of dysplasia. Gene mutations responsible for such common forms of dysplasia as lissencephaly and tuberous sclerosis have been identified, and investigators are beginning to understand how these gene mutations interrupt and/or misdirect the normal developmental pattern. Laboratory investigations, using animal models of cortical dysplasia, are beginning to elucidate how these structural malformations give rise to epilepsy and other functional pathologies.

Entities:  

Mesh:

Year:  2000        PMID: 11107192     DOI: 10.1002/1098-2779(2000)6:4<268::AID-MRDD6>3.0.CO;2-B

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  24 in total

1.  Initiation of epileptiform activity in a rat model of periventricular nodular heterotopia.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Emily T Doisy; Philip A Schwartzkroin
Journal:  Epilepsia       Date:  2011-09-20       Impact factor: 5.864

2.  REORGANIZATION OF BARREL CIRCUITS LEADS TO THALAMICALLY-EVOKED CORTICAL EPILEPTIFORM ACTIVITY.

Authors:  Qian-Quan Sun; John R Huguenard; David A Prince
Journal:  Thalamus Relat Syst       Date:  2005-12

3.  Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number.

Authors:  Brenda Luna; Sanjiv Bhatia; Changwon Yoo; Quentin Felty; David I Sandberg; Michael Duchowny; Ziad Khatib; Ian Miller; John Ragheb; Jayakar Prasanna; Deodutta Roy
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

Review 4.  Transcriptional regulation of neuronal polarity and morphogenesis in the mammalian brain.

Authors:  Luis de la Torre-Ubieta; Azad Bonni
Journal:  Neuron       Date:  2011-10-06       Impact factor: 17.173

5.  14-3-3ε and ζ regulate neurogenesis and differentiation of neuronal progenitor cells in the developing brain.

Authors:  Kazuhito Toyo-oka; Tomoka Wachi; Robert F Hunt; Scott C Baraban; Shinichiro Taya; Hayley Ramshaw; Kozo Kaibuchi; Quenten P Schwarz; Angel F Lopez; Anthony Wynshaw-Boris
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

6.  Nodule excitability in an animal model of periventricular nodular heterotopia: c-fos activation in organotypic hippocampal slices.

Authors:  Emily T Doisy; H Jürgen Wenzel; Yi Mu; Danh V Nguyen; Philip A Schwartzkroin
Journal:  Epilepsia       Date:  2015-03-06       Impact factor: 5.864

7.  Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit.

Authors:  Leena S Patel; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

8.  Continuous spike-waves during slow-wave sleep in a mouse model of focal cortical dysplasia.

Authors:  Qian-Quan Sun; Chen Zhou; Weiguo Yang; Daniel Petrus
Journal:  Epilepsia       Date:  2016-08-16       Impact factor: 5.864

9.  Glutamate biosensor imaging reveals dysregulation of glutamatergic pathways in a model of developmental cortical malformation.

Authors:  C G Dulla; H Tani; J Brill; R J Reimer; J R Huguenard
Journal:  Neurobiol Dis       Date:  2012-09-11       Impact factor: 5.996

10.  Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder.

Authors:  Jean-Bernard Manent; Yu Wang; Yoonjeung Chang; Murugan Paramasivam; Joseph J LoTurco
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.